Loading…

Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit

1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1990-07, Vol.100 (3), p.600-604
Main Authors: Feldman, J., Tibiriça, E., Bricca, G., Dontenwill, M., Belcourt, A., Bousquet, P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3
cites cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3
container_end_page 604
container_issue 3
container_start_page 600
container_title British journal of pharmacology
container_volume 100
creator Feldman, J.
Tibiriça, E.
Bricca, G.
Dontenwill, M.
Belcourt, A.
Bousquet, P.
description 1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously. 2 Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects. 3 The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine. 4 Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region. 5 In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.
doi_str_mv 10.1111/j.1476-5381.1990.tb15853.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15795369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</originalsourceid><addsrcrecordid>eNqVkcGP1CAYxYnRrOPqn2DSmLi3ViilFA9G3ayuySZ60DOh9MNhQssIne6Of710phn1tFk4QPJ-7_GRh9ArgguS1ptNQSpe54w2pCBC4GJsCWsYLe4eodVJeoxWGGOeE9I0T9GzGDcYJ5GzM3RWUoHrplyh8WqyHQwaMuNDNq4hs8Pk3QQ9DGPmTWZ726nf3tkBsgAatqMPMUEHVicoKJet91s_whDtBBkYA_pgDdalFNvN1sUQVNva8Tl6YpSL8GI5z9GPT1ffL6_zm6-fv1x-uMk1o4LmvOMNq1QJpcJVVdJOQYeFooaDYa1SVdplV2uiOVW4NFg3tWaaEUqhNhjoOXp3zN3u2h66ZVq5DbZXYS-9svJ_ZbBr-dNPkgjCG1ylgIslIPhfO4ij7G3U4JwawO-i5EIwXlf8XpAwLhitRQLfHkEdfIwBzGkaguVcrtzIuUE5NyjncuVSrrxL5pf__udkXdpM-utFV1ErZ4IatI1_XxCUY07rxL0_crfWwf4BE8iP364PV_oHFa_Fyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15795369</pqid></control><display><type>article</type><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><source>PubMed Central</source><creator>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</creator><creatorcontrib>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</creatorcontrib><description>1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously. 2 Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects. 3 The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine. 4 Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region. 5 In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1990.tb15853.x</identifier><identifier>PMID: 2390682</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Antihypertensive agents ; Antihypertensive Agents - administration &amp; dosage ; Antihypertensive Agents - pharmacology ; Biological and medical sciences ; Blood Pressure - drug effects ; Brain - physiology ; Cardiovascular system ; Cisterna Magna ; Dioxanes - pharmacology ; Heart Rate - drug effects ; Hemodynamics - drug effects ; Idazoxan ; Imidazoline Receptors ; Injections ; Injections, Intraventricular ; Male ; Medical sciences ; Oxazoles - administration &amp; dosage ; Oxazoles - pharmacology ; Pharmacology. Drug treatments ; Rabbits ; Receptors, Drug - physiology ; Rilmenidine ; Tissue Extracts - analysis ; Yohimbine - pharmacology</subject><ispartof>British journal of pharmacology, 1990-07, Vol.100 (3), p.600-604</ispartof><rights>1990 British Pharmacological Society</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</citedby><cites>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917804/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917804/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19370736$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2390682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feldman, J.</creatorcontrib><creatorcontrib>Tibiriça, E.</creatorcontrib><creatorcontrib>Bricca, G.</creatorcontrib><creatorcontrib>Dontenwill, M.</creatorcontrib><creatorcontrib>Belcourt, A.</creatorcontrib><creatorcontrib>Bousquet, P.</creatorcontrib><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously. 2 Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects. 3 The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine. 4 Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region. 5 In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</description><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - administration &amp; dosage</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Brain - physiology</subject><subject>Cardiovascular system</subject><subject>Cisterna Magna</subject><subject>Dioxanes - pharmacology</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Idazoxan</subject><subject>Imidazoline Receptors</subject><subject>Injections</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oxazoles - administration &amp; dosage</subject><subject>Oxazoles - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Receptors, Drug - physiology</subject><subject>Rilmenidine</subject><subject>Tissue Extracts - analysis</subject><subject>Yohimbine - pharmacology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNqVkcGP1CAYxYnRrOPqn2DSmLi3ViilFA9G3ayuySZ60DOh9MNhQssIne6Of710phn1tFk4QPJ-7_GRh9ArgguS1ptNQSpe54w2pCBC4GJsCWsYLe4eodVJeoxWGGOeE9I0T9GzGDcYJ5GzM3RWUoHrplyh8WqyHQwaMuNDNq4hs8Pk3QQ9DGPmTWZ726nf3tkBsgAatqMPMUEHVicoKJet91s_whDtBBkYA_pgDdalFNvN1sUQVNva8Tl6YpSL8GI5z9GPT1ffL6_zm6-fv1x-uMk1o4LmvOMNq1QJpcJVVdJOQYeFooaDYa1SVdplV2uiOVW4NFg3tWaaEUqhNhjoOXp3zN3u2h66ZVq5DbZXYS-9svJ_ZbBr-dNPkgjCG1ylgIslIPhfO4ij7G3U4JwawO-i5EIwXlf8XpAwLhitRQLfHkEdfIwBzGkaguVcrtzIuUE5NyjncuVSrrxL5pf__udkXdpM-utFV1ErZ4IatI1_XxCUY07rxL0_crfWwf4BE8iP364PV_oHFa_Fyg</recordid><startdate>199007</startdate><enddate>199007</enddate><creator>Feldman, J.</creator><creator>Tibiriça, E.</creator><creator>Bricca, G.</creator><creator>Dontenwill, M.</creator><creator>Belcourt, A.</creator><creator>Bousquet, P.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199007</creationdate><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><author>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - administration &amp; dosage</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Brain - physiology</topic><topic>Cardiovascular system</topic><topic>Cisterna Magna</topic><topic>Dioxanes - pharmacology</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Idazoxan</topic><topic>Imidazoline Receptors</topic><topic>Injections</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oxazoles - administration &amp; dosage</topic><topic>Oxazoles - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Receptors, Drug - physiology</topic><topic>Rilmenidine</topic><topic>Tissue Extracts - analysis</topic><topic>Yohimbine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feldman, J.</creatorcontrib><creatorcontrib>Tibiriça, E.</creatorcontrib><creatorcontrib>Bricca, G.</creatorcontrib><creatorcontrib>Dontenwill, M.</creatorcontrib><creatorcontrib>Belcourt, A.</creatorcontrib><creatorcontrib>Bousquet, P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feldman, J.</au><au>Tibiriça, E.</au><au>Bricca, G.</au><au>Dontenwill, M.</au><au>Belcourt, A.</au><au>Bousquet, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1990-07</date><risdate>1990</risdate><volume>100</volume><issue>3</issue><spage>600</spage><epage>604</epage><pages>600-604</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously. 2 Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects. 3 The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine. 4 Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region. 5 In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2390682</pmid><doi>10.1111/j.1476-5381.1990.tb15853.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1990-07, Vol.100 (3), p.600-604
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917804
source PubMed Central
subjects Animals
Antihypertensive agents
Antihypertensive Agents - administration & dosage
Antihypertensive Agents - pharmacology
Biological and medical sciences
Blood Pressure - drug effects
Brain - physiology
Cardiovascular system
Cisterna Magna
Dioxanes - pharmacology
Heart Rate - drug effects
Hemodynamics - drug effects
Idazoxan
Imidazoline Receptors
Injections
Injections, Intraventricular
Male
Medical sciences
Oxazoles - administration & dosage
Oxazoles - pharmacology
Pharmacology. Drug treatments
Rabbits
Receptors, Drug - physiology
Rilmenidine
Tissue Extracts - analysis
Yohimbine - pharmacology
title Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20the%20involvement%20of%20imidazoline%20receptors%20in%20the%20central%20hypotensive%20effect%20of%20rilmenidine%20in%20the%20rabbit&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Feldman,%20J.&rft.date=1990-07&rft.volume=100&rft.issue=3&rft.spage=600&rft.epage=604&rft.pages=600-604&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1990.tb15853.x&rft_dat=%3Cproquest_pubme%3E15795369%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15795369&rft_id=info:pmid/2390682&rfr_iscdi=true